Search results for: 'computation frost dynamics cd'

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

28 Jan 2020  |  North America  |  Market Research

Global Healthcare Cloud Computing Market, Forecast to 2023

Competitive Dynamics are Pushing Services to the Forefront

Infographics

×

Key Issues Addressed

Cloud computing in healthcare is gaining momentum as a variety of factors create a significant need for the value propositions that a successful cloud implementation promises to offer. Global healthcare cloud market revenue is expected to surge at a compound annual growth rate of 25.1% from 2018 to 2023. Cloud computing involves the use of exter...

Frost & Sullivan’s global team of analysts and consultants research a wide range of industries. Primary and secondary analysis spans the entire value chain, identifying organizations that consistently develop new growth strategies based on a visionary understanding of the future and a proven ability to effectively address emerging challenges and op...

Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform. This repo...

01 Jul 2021  |  North America  |  Market Research

Global Computed Tomography Growth Opportunities

Increased Demand and Purchase Parameters on Multivariate Trends Propel Transformational Growth

Infographics

×

An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing annually by 3%–4%. CT has become an indispensable tool in illness diagnosis and management, playing an instrumental role in COVID-19 management. The dynamic CT industry involves many participants introducing technological innovations frequently to ma...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

This Frost & Sullivan research service focuses on US Department of Defense (DoD) artificial intelligence (AI) budget spending and contracts. Artificial intelligence tools are used across an array of DoD applications to enhance mission accomplishment and safety, including logistics, maintenance, healthcare, administration, networks, intelligence ana...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

Consumer headphones have grown into a double-digit billion-dollar market over the last years, which generated revenue of almost USD 14.13 Billion in 2018. Apple-owned Beats Electronics, and Bose, have been leading the market. Harman has stood out for particular growth momentum over the last years. At the same time, the mono Bluetooth (BT) headset m...